Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 260,843 | 173,959 | 281,080 | 306,744 | 346,850 |
| Marketable Securities | 1,476,335 | 1,387,000 | 1,430,240 | 1,354,683 | 1,324,881 |
| TOTAL | $1,813,488 | $1,627,361 | $1,767,167 | $1,715,775 | $1,716,563 |
| Non-Current Assets | |||||
| PPE Net | 260,695 | 257,370 | 253,486 | 242,266 | 217,155 |
| Investments And Advances | 1,004,017 | 881,664 | 959,256 | 1,165,091 | 1,279,031 |
| Other Non-Current Assets | 270,108 | 236,322 | 191,691 | 182,231 | 165,354 |
| TOTAL | $1,534,820 | $1,375,356 | $1,404,433 | $1,589,588 | $1,661,540 |
| Total Assets | $3,348,308 | $3,002,717 | $3,171,600 | $3,305,363 | $3,378,103 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63,060 | 70,904 | 48,962 | 31,414 | 20,514 |
| Accrued Expenses | 30,247 | 31,068 | 24,592 | 32,214 | 26,042 |
| TOTAL | $242,082 | $205,750 | $200,046 | $154,486 | $96,996 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 110,212 | 111,457 | 78,672 | 79,543 | 81,081 |
| TOTAL | $110,212 | $111,457 | $78,672 | $79,543 | $81,081 |
| Total Liabilities | $352,294 | $317,207 | $278,718 | $234,029 | $178,077 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,398 | 143,920 | 130,906 | 129,823 | 129,004 |
| Common Shares | 147 | 134 | 133 | 133 | 132 |
| Retained earnings | -2,475,569 | -2,154,947 | -1,908,440 | -1,695,610 | -1,529,037 |
| Other shareholders' equity | -6,834 | 1,587 | 856 | -1,887 | -322 |
| TOTAL | $2,996,014 | $2,685,510 | $2,892,882 | $3,071,334 | $3,200,026 |
| Total Liabilities And Equity | $3,348,308 | $3,002,717 | $3,171,600 | $3,305,363 | $3,378,103 |